Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "fr ii"

Resumen: ERYTECH anuncia inscripción de primer paciente en es...

LYON, Francia--( BUSINESS WIRE )-- ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), la empresa biofarmacéutica francesa que desarrolla tratamientos innovadores centrados en la "inanición de los tumores" para la ... Business Wire, 3 days ago
[x]  

26 images for fr ii

Manila Bulletin, 2 months ago
Manila Times, 2 months ago
St. Mary's College of California, 2 months ago
Catholic Herald, 3 months ago
Vatican Radio, 2 months ago
Clare Champion, 2 months ago
France24, 2 months ago
France24, 3 months ago
France24, 3 months ago
France24, 3 months ago

エリテック、米国にて急性リンパ芽球性白血病を対象に ERY-ASPを検討する第 I/II 相試験で、初の患者組み入れを発表

仏リヨン--( BUSINESS WIRE )--(ビジネスワイヤ) -- ...
 Business Wire2 days ago Riassunto: ERYTECH rende noto l'arruolamento del primo paziente nello studio di Fase I/II con ERY-ASP nella leucemia linfoblastica acuta negli Stati Uniti  Business Wire3 days ago

The Dispersion of Silver Iodide Particles from Ground-Based Generators over Complex Terrain. Part II: WRF Large-Eddy Simulations versus Observations [Journal of Applied Meteorology and Climatology]

(Journal of Applied Meteorology and Climatology Via Acquire Media NewsEdge) ABSTRACT A numerical modeling study has been conducted to explore the ability of the Weather Research and Forecasting (WRF) model-based large-eddy simulation (LES) with ...
 TMC Net1 week ago
Mangalorean

Mangalore: Fr Ignatius DSouza Appointed New Bishop of Bareilly

Mangalore: Pope Francis on Friday 11th July 2014 appointed Fr Ignatius DSouza, Vicar General of the Diocese of Lucknow, as the new Bishop of Bareilly succeeding Bishop Anthony Fernandes whose resignation has been accepted. The appointment of the new ...
 Mangalorean1 week ago
Scottrade

Teleperformance: Monthly Information Regarding Shares and Voting Rights

Teleperformance: Monthly Information Regarding Shares and Voting Rights (Article L.233-8 II of the French Commercial Code and Article 223-16 of the «Réglement général» of the AMF) Regulatory News: ...
 Reuters2 weeks ago RENAULT : Information relating to the total number of voting rights and share capital  Reuters2 weeks ago Axway: Disclosure of the Total Number of Voting Rights and Shares that Comprise the Share Capital Social as at June 30, 2014  Scottrade2 weeks ago ALBIOMA :Total number of shares and voting rights in the share capital as at July 2nd 2014  Reuters2 weeks ago
[x]  

Have to wait and watch for Modi's avatar II: Digvijay Singh

Days after his party colleague Shashi Tharoor observed that Prime Minister Narendra Modi was taking an avatar of modernity and progress, senior Congress leader Digvijay Singh today said it was too early to say any thing about him and one has to wait and watch ...
 Deccan Herald1 month ago
NDTV

Queen Elizabeth II Unveils British Government Plan

Queen Elizabeth II unveiled the British government's legislative agenda Wednesday in a ceremony that combined a sumptuous display of pomp and power with a slim slate of bills on crime, pensions and fracking. The annual Queen's Speech is both a policy ...
 NDTV1 month ago
EuroInvestor

INNATE PHARMA : Completion of target enrollment in the phase II EffiKIR trial

Data on primary efficacy endpoint Leukemia-Free Survival expected end of 2015 MARSEILLE, France, July 24, 2014 (GLOBE NEWSWIRE) -- Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH), the innate immunity company developing ...
 Financial Content1 day ago Innapharma: Completion Of Target Enrollment In The Phase 2 EffiKIR Trial  BioSpace20 hours ago Innate Pharma SA concludes target enrollment of 150 Acute Myeloid Leukemia patients in EffiKIR trial  Individual.com1 hour ago
[x]  
Scottrade

Consortium of Food Allergy Research Completes Recruitment of NIH-sponsored CoFar6 Phase II Trial with DBV's Viaskin(r) Peanut in Treatment of Peanut Allergy

Leading US centers in food allergy involved in an NIH-funded CoFAR6 study, co-chaired by Dr. Hugh Sampson and Dr. Stacie Jones NEW YORK and BAGNEUX, France, July 17, 2014 (GLOBE NEWSWIRE) -- DBV Technologies ( Euronext: DBV - ISIN: ...
 Minyanville1 week ago DBV TECHNOLOGIES : Consortium of Food Allergy Research Completes Recruitment of NIH-sponsored CoFar6 Phase II Trial with DBV's Viaskin® Peanut in Treatment of Peanut Allergy  4 Traders1 week ago DBV Technologies Completes last "food challenge" visit of last Peanut-Allergic patient in VIPES Phase IIb Clinical Study  Reuters1 week ago DBV TECHNOLOGIES : Completes last "food challenge" visit of last Peanut-Allergic patient in VIPES Phase IIb Clinical Study  4 Traders1 week ago
[x]  
EuroInvestor

Sodexo: Organic Revenue Growth of 2.3% for the First Nine Months of Fiscal 2014

ISSY-LES-MOULINEAUX, France, July 9, 2014 (GLOBE NEWSWIRE) -- Sodexo (NYSE Euronext Paris FR 0000121220-OTC: SDXAY), the world leader in Quality of Life Services, today reported its revenues for the first nine months of Fiscal 2014, which ended on ...
 Morningstar.com2 weeks ago SODEXO : Organic Revenue Growth of 2.3% for the First Nine Months of Fiscal 2014  4 Traders2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less